about
PharmGKB summary: very important pharmacogene information for UGT1A1Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir PrescribingNew insights in bilirubin metabolism and their clinical implicationsLineage-Specific Changes in Biomarkers in Great Apes and HumansDevelopmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.Digital quantification of human eye color highlights genetic association of three new loci.Addressing the challenges of the clinical application of pharmacogenetic testingBilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1.Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans.Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors.Evaluating elevated bilirubin levels in asymptomatic adultsUse of antineoplastic agents in patients with cancer who have HIV/AIDS.Prevalence of topoisomerase I genetic mutations and UGT1A1 polymorphisms associated with irinotecan in individuals of Asian descentIndividualization of antiretroviral therapy.Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactionsBilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.Gilbert syndrome: the UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism.A review of pharmacogenetics of adverse drug reactions in elderly people.Pharmacogenetics of antiretroviral therapy.Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia.Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients."Gilbert's-like" syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients.Regulation of UGT1A expression by miR-298 in human livers from the Han Chinese population and in human cell lines.Hydrogel microarray for detection of polymorphisms in the UGT1A1, DPYD, GSTP1 and ABCB1 genes.Multiple origins of green blood in New Guinea lizards.
P2860
Q24562836-D48B9C79-0C81-4A68-AFE6-675C9FB972F4Q26784507-5B915847-656F-419A-8ECA-B109E4946031Q26863145-718E3CD1-4AC0-441C-94FF-4340FDE64496Q28547060-20D971C7-32AC-4E7F-B804-48FA071B914BQ30493784-62695F5E-4D41-425E-ADE1-42CC30F76A16Q33576746-ABB6FF81-0E1A-4B36-BA93-4E3D1A24AC90Q34022094-EBB64A49-7838-4950-AD89-1A7443C7E026Q34257505-EAEAF789-57CF-4B99-B10D-055CE04E769CQ34305121-AE589D72-574E-4411-9EF5-820FBCAFED62Q34551930-88F8D302-0EF3-4D66-A534-4A9FD26F71EBQ35585207-E0C3671E-96E7-44F9-A0B1-6CBB6427872FQ35932561-F884E455-0B6D-487D-8C5F-54849DCEFC07Q36126605-EAFD179D-AD80-4B8B-BEDA-DD3EFF530B70Q36441423-6DE7D559-DA01-4AC0-96E3-DB5C9D2E20C6Q36450835-2540F288-D9DE-46F9-B868-7D26F2E128BAQ36475104-E04C9137-261F-4023-98BF-21E4112D612AQ37267060-A75E9856-0148-4EAE-B507-EA7B4FB013D5Q37685527-70D583A7-37F8-43E7-AE40-8E312DA60861Q37990054-94D56200-BD58-465D-AB00-6515052B0124Q37997047-225BFE78-4EA9-4700-A828-208D44E16649Q38085220-F0808E1F-471C-4F64-85FD-33FF7B79662BQ38221179-ABC42E75-77D7-4066-B519-F928099EABEBQ39173495-B1A3761B-CA0B-4633-B5F4-8A48F56F4B76Q43195722-63C2E9DE-9C1D-4D82-A28C-A4007EC94FE0Q45456321-B9FCBD61-64A4-4B80-A64D-8AD3FA710837Q49543181-8ECF67AE-0579-4C6E-8CE8-7AFA58EA4E69Q49668137-2DA12CB1-F9C0-42B2-ADEF-EB50E30C008FQ51192899-F39E6C6D-0807-434E-B176-4F935ED2AAFFQ55381728-4B8BAADF-24A3-4AA1-88CB-2B6F435FF7B9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetics of Gilbert's syndrome.
@en
Pharmacogenetics of Gilbert's syndrome.
@nl
type
label
Pharmacogenetics of Gilbert's syndrome.
@en
Pharmacogenetics of Gilbert's syndrome.
@nl
prefLabel
Pharmacogenetics of Gilbert's syndrome.
@en
Pharmacogenetics of Gilbert's syndrome.
@nl
P2860
P356
P1433
P1476
Pharmacogenetics of Gilbert's syndrome.
@en
P2093
Christian P Strassburg
P2860
P304
P356
10.2217/14622416.9.6.703
P577
2008-06-01T00:00:00Z